Jazz Pharmaceuticals PLC (JAZZ)

Number of days of payables

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Payables turnover		19.00	17.52	21.28	16.88	23.69	21.37	27.98	29.04	19.72	27.21	22.93	15.07	46.39	19.73	25.80	19.22	23.87	10.55	6.43	7.74
Number of days of payables	days	19.21	20.83	17.15	21.63	15.41	17.08	13.04	12.57	18.51	13.42	15.92	24.23	7.87	18.50	14.15	18.99	15.29	34.60	56.77	47.17

December 31, 2023 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 19.00
= 19.21

Jazz Pharmaceuticals plc's number of days of payables has shown fluctuations over the past eight quarters. In Q4 2023, the company took approximately 86.10 days on average to pay its suppliers, which was higher compared to the prior quarter at 80.89 days. The increase in days of payables indicates that Jazz Pharmaceuticals took a longer time to settle its outstanding obligations to suppliers in Q4 2023.

Looking at historical trends, Q2 2022 had the lowest number of days of payables at 51.97 days, while the highest number of days was observed in Q4 2022 at 73.28 days. This suggests that the company has experienced variability in its payment cycle over the past two years.

Overall, monitoring the number of days of payables can provide insights into how efficiently Jazz Pharmaceuticals manages its working capital and relationships with suppliers. An increasing trend in the days of payables may indicate a cash flow advantage for the company, while a decreasing trend could signal potential liquidity challenges or changes in payment terms.